by admin | Dec 4, 2024 | News & Opinions
By VHIO – One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast cancer with a poorer prognosis. Investigators of the VHIO’s Growth Factors Group, and the Cancer Research Program of Hospital del...
by admin | Dec 3, 2024 | News & Opinions
By The Engineer – Engineers at Nottingham University have 3D-printed blood-based regenerative materials that mimic natural healing processes and enhance recovery. Described in Advanced Materials, the ‘biocooperative’ materials combine a subject’s own blood with...
by admin | Dec 2, 2024 | News & Opinions
By Genetic Engineering and Biotechnology News Clinical trial results are showing the first successes against solid tumors for CAR-T cells. The findings offer hope for children with a group of deadly brain and spinal cord tumors, including a cancer called diffuse...
by admin | Nov 29, 2024 | News & Opinions
By Andis Robeznieks – American Medical Association – It is critically important to make health IT accessible for all and to achieve equitable adoption among aging patients, people with hearing and eyesight impairment, as well as those who live in...
by admin | Nov 28, 2024 | News & Opinions
by Emily Mullin – Wired – It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder. It’s finally being infused into patients. Called Casgevy, the gene-editing treatment is for people with...
